利用工程细菌作为"细胞工厂"在vivo内用于细胞内RNA载荷外膜囊泡的自我组装在瘤治疗中
Dawei Sun1, Yize Li2, Xiaoxuan Yin1
1School of Life Sciences, Faculty of Medicine, Tianjin Engineering Center of Micro-Nano Biomaterials and Detection-Treatment Technology, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin University, Tianjin 300072, China.
ACS nano
|December 18, 2024
概括
工程细菌通过作为体内细胞工厂来提供RNA疗法. 这种新的系统简化了RNA输送,并显示出显著的瘤抑制,为癌症治疗提供了一种有前途的方法.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 治疗方法 治疗方法
背景情况:
- 目前的RNA传递系统复杂,需要体外预组装,冷链运输和多次注射.
- 这些局限性阻碍了基于RNA的疗法的效率和可访问性.
研究的目的:
- 使用工程细菌开发一种简化和高效的RNA输送系统.
- 通过细菌外膜囊泡 (OMVs) 证明体内RNA的产生和传递.
主要方法:
- 工程细菌被开发为在体内细胞工厂,用于连续的RNA生产.
- 目标RNA与细菌OMV自组合,用于增强体内传递.
- 该系统的有效性与mRNA,miRNA和siRNA进行了测试,包括用于瘤治疗的PD-L1siRNA.
主要成果:
- 工程系统在OMV中实现了高相对丰度的点RNA (10^4-10^7倍高于对照).
- 输送PD-L1siRNA导致基因表达的下调约为两倍.
- 一次注射工程细菌导致显著的体内瘤抑制 (49.37%).
结论:
- 这种基于细菌的工程系统提供了一种简单,稳定和连续的 in vivo RNA 输送方法.
- 这种方法表明了有效的RNA疗法的潜力,特别是在癌症治疗中.
- 这项技术为推进基于RNA的疗法提供了一个有希望的新平台.
相关概念视频
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.


